Does Treating Obstructive Sleep Apnea in Obese Canadian Youth Improve Blood Sugar Control?

NCT01116375 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2018-03-09

No results posted yet for this study

Summary

To determine whether, in obese children with moderate-severe Obstructive Sleep Apnea who are prescribed Positive Airway Pressure(PAP) therapy, increased hours of PAP usage per night over a one-year period is associated with a greater improvement in HOMA-IR

Conditions

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV
  • Katz, Sherri Lynne, M.D.

    lead INDIV

Principal Investigators

  • Evelyn Constantin, MD · Montreal Children's Hospital of the MUHC

  • Sherri L Katz, md · Childrens Hospital of Eatern Ontario

Eligibility

Min Age
8 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2014-07-31
Completion
2014-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01116375 on ClinicalTrials.gov